LONDON, Sept. 19, 2016 /PRNewswire/ -- Interface technologies trigger novel opportunities
Brain-Computer Interface (BCI) is currently one of the most investigated areas in healthcare and consumer electronics. Non-invasive BCI has found multiple uses in the areas of medicine such as motor restoration, wheelchair assistance, and treatment of neurological disorders.
The BCI market has witnessed an upward trend in the last decade owing to its utility in a number of medical applications. Non-invasive approaches of BCI have been successfully used to treat partially paralyzed patients by helping them regain their mobility and confidence. Although non-invasive approaches provide outstanding utility, invasive techniques are still needed as the resolution of brain signals received from non-invasive techniques is not up to the mark. Invasive modalities are essential for accurate neuroprosthetics control. As invasive BCI modalities require regulatory approvals, manufacturers are less willing to fund clinical trials associated with the approval process.